Cipla Limited Appoints Vice-Chairman, Approves Investment and Amalgamation
Cipla Limited announced several key developments following a board meeting held on March 19, 2026. Mr. P R Ramesh, Lead Independent Director, has been designated as Vice-Chairman, effective April 1, 2026. Robert Stewart, an Independent Director, will not seek re-appointment upon the completion of his term on May 13, 2026.The company approved an investment of USD 100 million in the equity share capital of Cipla (EU) Limited, a wholly-owned subsidiary, to provide financial assistance to InvaGen Pharmaceuticals Inc., another wholly-owned subsidiary of Cipla (EU) Limited. This investment will support capital expenditure, working capital requirements, and general corporate purposes.
Cipla also approved a Scheme of Amalgamation of Inzpera Healthsciences Limited, a wholly-owned subsidiary, with the company. The amalgamation requires approvals under the Companies Act, 2013, including approval from the National Company Law Tribunal, Mumbai. Cipla anticipates the amalgamation will not have a material impact on its financials.
Financial Details of Cipla (EU) Limited
The following table summarizes the financial details of Cipla (EU) Limited:
| Particulars | Details | Details |
|---|---|---|
| Turnover | 3.76 (USD crore) | |
| Profit After Tax | 0.60 (USD crore) | |
| FY 2024-25 Turnover | 3.76 (USD crore) | |
| FY 2023-24 Turnover | 2.51 (USD crore) | |
| FY 2022-23 Turnover | 2.91 (USD crore) |
Amalgamation Details
The amalgamation does not involve any consideration, as Inzpera is a wholly-owned subsidiary of Cipla. All shares of Inzpera will be cancelled upon the scheme's effectiveness.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: